期刊文献+

氟比洛芬口服混悬剂的兔药物动力学及其生物利用度 被引量:5

Study on pharmacokinetics and bioavailability of flurbiprofen suspension in rabbits
下载PDF
导出
摘要 目的:研究氟比洛芬口服给药的药物动力学及生物利用度。方法:利用HPLC法测定氟比洛芬的血药浓度,以交叉给药方式分别给予家兔注射剂和口服混悬剂并且对其药物动力学和生物利用度进行研究。结果:氟比洛芬在家兔体内药动学静脉注射符合二室开放模型,口服符合一室开放模型,氟比洛芬口服混悬剂的绝对生物利用度为61.9%。结论:在进行氟比洛芬剂型研究时应注重提高其口服制剂的生物利用度。 OBJECTIVE:To study the pharmacokinetics and bioavailabilities of flurbiprofen suspension.METHODS:A reversed phase HPLC was established to determine serum flurbiprofen concentration,the pharmacokinetics and bioavailability of FP were investigated in 6 rabbits.RESULTS:The results showed that the pharmacokinetics of FP conformed to two compartment open models after injective administration of FP, and the pharmacokinetics of FP conformed to one compartment open models after oral administration, the bioavailability of the suspension against the injection was 61.9% .CONCLUSION:Improving the bioavailability of FP preparation should be considered.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 1999年第12期707-709,共3页 Chinese Journal of Hospital Pharmacy
关键词 HPLC 生物利用度 药物动力学 氟比洛芬 flurbiprofen, pharmacokinetics, bioavailability, HPLC
  • 相关文献

同被引文献28

  • 1林佳亮,王庭贤,苏云驰,曾凡波,金晶,王涛.双氯芬酸钠贴剂绝对生物利用度和局部组织药物浓度研究[J].中国药师,2004,7(11):834-836. 被引量:6
  • 2FAKHREDDIN J, DAVID S C, BRIAN W B, et al. Comparative bioavailability of two flurbiprofen products: stereospecific versus conventional approach [ J ]. Biopharm Drug Dispos, 1991, 12 : 435-445.
  • 3[1]Dayan N, Toutie E. Carriers for skin delievery of trihexphenidyl HCl:ethosome vs liposome [J]. Biomaterials, 2000,21(18):1879~1885.
  • 4[2]Toutie E, Bergelson L,Godin B, et al. Ethosome-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties[J]. J Controlled Release, 2000,65 (3):403~418.
  • 5Kommuru TR, Gurley B, Khan MA, et al. Self-emulsifyingdrug delivery systems (SEDDS) of eoenzyme Q10: formulation development and bioavailability assessment[J].Int J Pharm,2001,212(2) :233-246.
  • 6Gershanik T, Benita S. Self disperiing lipid formulations for improving oral absorption of lipophilie drugs[J].Eur J Pharm Bio,2000,50(2) : 179-188.
  • 7Rege BD, Kao JPY, PoLli JE. Effects of nonionic surfactant membrane transporters in Caco-2 cell monolayers[J].Eur J Pharm Sci, 211112,16 (4-5): 237-246.
  • 8Cornaire G,Woodley J, Hermann P, et al. Impact of excipientson the absorption of P-glycoprotein substrates in vitro and in vivo[J].Int J Pharm, 2004,278(1 ) : 119-131.
  • 9Kommuru TR,Gurley B,Khan MA,et al.Self-emulsifyingdrug delivery systems (SEDDS) of coenzyme Q10:formula-tion development and bioavailability assessment[J].Int J Pharm,2001,212(2):233-246.
  • 10Gershanik T,Benita S.Self disperiing lipid formulations for improving oral absorption of lipophilic drugs[J].Eur J Pharm Bio,2000,50(2):179-188.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部